Tumor News and Research

RSS

Study reveals a loophole in treatment of chronic lymphocytic leukemia

A team of researchers in Italy and Austria has determined that a drug approved to treat chronic lymphocytic leukemia (CLL) may be less effective in a particular subset of patients.

4 Jan 2018

Researchers develop new compound that inhibits growth of melanoma cells

An international team of researchers has developed a novel compound that successfully inhibits growth of melanoma cells by targeting specific epigenetic modifying proteins in these cells.

4 Jan 2018

Supercomputers help scientists to devise cancer models for predicting individual treatment outcomes

Attempts to eradicate cancer are often compared to a "moonshot" -- the successful effort that sent the first astronauts to the moon.

3 Jan 2018

New MRI technology can reduce need for tumor biopsies

The most common type of tumor found in the kidney is generally quite small (less than 1.5 in). These tumors are usually found by accident when CAT scans are performed for other reasons and the serendipitous finding poses a problem for doctors.

3 Jan 2018

Experimental diabetes drugs can make cancer cells vulnerable to chemotherapy agents

Scientists at Dana-Farber Cancer Institute have shown that experimental diabetes drugs can make cancer cells more vulnerable to traditional chemotherapy agents, and they say such combinations should be explored to potentially improve outcomes for cancer patients.

2 Jan 2018

Novel nanomedicine prolongs survival of pancreatic tumor-bearing mice

A new Tel Aviv University study pinpoints the inverse correlation between a known oncogene -- a gene that promotes the development of cancer -- and the expression of an oncosuppressor microRNA as the reason for extended pancreatic cancer survival.

2 Jan 2018

Terrifying brush with death drives doctor to fight for patients

The searing abdominal pain came on suddenly while Dr. Rana Awdish was having dinner with a friend. Soon she was lying in the back seat of the car racing to Henry Ford Hospital in Detroit, where Awdish was completing a fellowship in critical care.

2 Jan 2018

Macrophages play major role in helping early breast cancer cells spread even before tumor develops

Mount Sinai researchers have discovered that normal immune cells called macrophages, which reside in healthy breast tissue surrounding milk ducts, play a major role in helping early breast cancer cells leave the breast for other parts of the body, potentially creating metastasis before a tumor has even developed, according to a study published in Nature Communications.

2 Jan 2018

UAB study shows missense mutations as key risk factor for severe symptoms of neurofibromatosis type 1

Research led by Ludwine Messiaen, Ph.D., professor of genetics at the University of Alabama at Birmingham, shows that missense mutations in a cluster of just five codons in the NF1 gene are an important risk factor for severe symptoms of the genetic disease neurofibromatosis type 1.

28 Dec 2017

Researchers reveal how tumor cells disrupt circadian rhythm to survive

Tumor cells use the unfolded protein response to alter circadian rhythm, which contributes to more tumor growth, Hollings Cancer Center researchers at the Medical University of South Carolina find.

28 Dec 2017

$Study uncovers genomic targets in refractory neuroblastoma$

Study uncovers genomic targets in refractory neuroblastoma

Neuroblastoma (NB) is the most common solid tumor found in children. It starts in some very early forms of nerve cells found in the embryo or fetus.

28 Dec 2017

Reduced activity of transcription factor plays key role in triggering pulmonary fibrosis

To date, the molecular basis of pulmonary fibrosis has been poorly understood. Scientists from the Max Planck Institute for Heart and Lung Research in Bad Nauheim have now shown that reduced activity of the transcription factor FoxO3 plays a key role in the development of the disease.

26 Dec 2017

Novel GammaPod system receives FDA clearance to treat early stage breast cancer

The GammaPod - a first-of-its kind stereotactic radiotherapy system to treat early stage breast cancer - has received 510(k) clearance from the U.S. Food and Drug Administration, paving the way for the manufacturer to bring the system to market for the treatment of breast cancer patients.

26 Dec 2017

Nanobiotix receives FDA approval for first immuno-oncology trial

NANOBIOTIX, a late clinical-stage nanomedicine company pioneering new approaches to the treatment of cancer, today announced the U.S. Food and Drug Administration has approved its Investigational New Drug Application for NBTXR3, a first-in-class nanoparticle designed for direct injection into cancerous tumors, activated by stereotactic ablative radiotherapy (SABR) and administered in combination with an anti-PD1 antibody (nivolumab or pembrolizumab).

26 Dec 2017

Novartis announces FDA approval of its first and only CML therapy with TFR data in product label

Novartis announced today that the US Food and Drug Administration (FDA) approved the inclusion of Treatment-free Remission (TFR) data in the Tasigna® (nilotinib) US product label.

26 Dec 2017

Novel radiotherapy system receives FDA clearance for treating early stage breast cancer

The GammaPod – a first-of-its kind stereotactic radiotherapy system to treat early stage breast cancer – has received 510(k) clearance from the U.S. Food and Drug Administration, paving the way for the manufacturer to bring the system to market for the treatment of breast cancer patients.

22 Dec 2017

Tumor News and Research

Study reveals a loophole in treatment of chronic lymphocytic leukemia

Researchers develop new compound that inhibits growth of melanoma cells

Supercomputers help scientists to devise cancer models for predicting individual treatment outcomes

New MRI technology can reduce need for tumor biopsies

Experimental diabetes drugs can make cancer cells vulnerable to chemotherapy agents

Novel nanomedicine prolongs survival of pancreatic tumor-bearing mice

Terrifying brush with death drives doctor to fight for patients

Macrophages play major role in helping early breast cancer cells spread even before tumor develops

UAB study shows missense mutations as key risk factor for severe symptoms of neurofibromatosis type 1

Researchers reveal how tumor cells disrupt circadian rhythm to survive

Study uncovers genomic targets in refractory neuroblastoma

Reduced activity of transcription factor plays key role in triggering pulmonary fibrosis

Novel GammaPod system receives FDA clearance to treat early stage breast cancer

Nanobiotix receives FDA approval for first immuno-oncology trial

Novartis announces FDA approval of its first and only CML therapy with TFR data in product label

Novel radiotherapy system receives FDA clearance for treating early stage breast cancer

Researchers sequence salamander genome to reveal unique features of regeneration

New method sifts through millions of molecular targets to find precise tumor beacon

Proton therapy center for treating cancer patients coming to Utah

Study suggests new target to treat prostate cancer

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News